Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea

about

Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease.

P2860

Q34882331-B5271425-DC1C-4B46-BF82-6691AA775387

P2860

Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea

Item

http://www.wikidata.org/entity/Q36817410

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@ast

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@en

type

Item

label

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@ast

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@en

prefLabel

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@ast

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@en

P1476

Predictable Marker for Regress ...... p Inhibitor Treatment in Korea

@en

P2093

Dong Ho Lee

http://www.w3.org/2001/XMLSchema#string

Hye Seung Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Chae Jung

http://www.w3.org/2001/XMLSchema#string

Hyun Chang

http://www.w3.org/2001/XMLSchema#string

Hyun Jin Jo

http://www.w3.org/2001/XMLSchema#string

Jane C Oh

http://www.w3.org/2001/XMLSchema#string

Min Soo Kim

http://www.w3.org/2001/XMLSchema#string

Ryoung Hee Nam

http://www.w3.org/2001/XMLSchema#string

Sung Eun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression

The Ki-67 protein: from the known and the unknown

Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.

Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data.

A 2008 questionnaire-based survey of gastroesophageal reflux disease and related diseases by physicians in East Asian countries.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Natural history of Barrett's esophagus.

Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers

Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

P304

210-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5056/JNM.2013.19.2.210

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nayoung Kim

P577

2013-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236693519

http://www.w3.org/2001/XMLSchema#string

P698

23667752

http://www.w3.org/2001/XMLSchema#string

P932

3644657

http://www.w3.org/2001/XMLSchema#string

Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea

about

P2860

P2860

Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932